---
title: "US Stock Market News | LaiLi Financial Raises Target Price to $26, Novavax Pharmaceuticals Rises Over 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/216473053.md"
description: "On Thursday, Novavax Pharmaceuticals fluctuated and rose more than 5% at one point, and as of the time of publication, it rose over 3% to $13.08. On the news front, Riley Financial analyst Mayank Mamtani maintained a \"buy\" rating on Novavax Pharmaceuticals and raised the target price from $23 to $26"
datetime: "2024-10-10T15:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/216473053.md)
  - [en](https://longbridge.com/en/news/216473053.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/216473053.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/216473053.md) | [繁體中文](https://longbridge.com/zh-HK/news/216473053.md)


# US Stock Market News | LaiLi Financial Raises Target Price to $26, Novavax Pharmaceuticals Rises Over 3%

On Thursday, Novavax (NVAX.US) fluctuated and rose more than 5% at one point, and as of the time of publication, it has risen more than 3% to $13.08. On the news front, Riley Financial analyst Mayank Mamtani maintained a "buy" rating on Novavax and raised the target price from $23 to $26

### Related Stocks

- [Novavax, Inc. (NVAX.US)](https://longbridge.com/en/quote/NVAX.US.md)

## Related News & Research

- [BUZZ-Novavax rises after naming internal medicine specialist as R&D head](https://longbridge.com/en/news/281018084.md)
- [Nike's results were better than expected, but investors still aren't sold on its turnaround](https://longbridge.com/en/news/281245718.md)
- [Norfolk Southern Earnings Preview: What to Expect](https://longbridge.com/en/news/280999046.md)
- [Did Nike's Turnaround Just Hit a Wall? Here's What Investors Need To Know](https://longbridge.com/en/news/281298140.md)
- [What's Going On With Nokia Stock Tuesday?](https://longbridge.com/en/news/281192960.md)